We are live on ! Find out more
VMD icon

Viemed Healthcare

121 hedge funds and large institutions have $186M invested in Viemed Healthcare in 2024 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 41 increasing their positions, 26 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

211% more call options, than puts

Call options by funds: $59K | Put options by funds: $19K

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

58% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 26

40% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 15

11% more capital invested

Capital invested by funds: $167M → $186M (+$19M)

4% more funds holding

Funds holding: 116121 (+5)

0.57% less ownership

Funds ownership: 65.49%64.92% (-0.57%)

Holders
121
Holders Change
+5
Holders Change %
+4.31%
% of All Funds
1.74%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
21
Increased
41
Reduced
26
Closed
15
Calls
$59K
Puts
$19K
Net Calls
+$40K
Net Calls Change
+$122K
Name Holding Trade Value Shares
Change
Change in
Stake
Thrivent Financial for Lutherans
1
Thrivent Financial for Lutherans
Minnesota
$25.1M +$150K +21,047 +0.6%
BlackRock
2
BlackRock
New York
$21.8M +$470K +65,772 +2%
WA
3
Wasatch Advisors
Utah
$13.6M +$2.17M +303,277 +20%
FCM
4
Forager Capital Management
Alabama
$13.3M -$71 -10 -0%
Vanguard Group
5
Vanguard Group
Pennsylvania
$13.3M +$215K +30,035 +2%
KLP
6
Kent Lake PR
Puerto Rico
$9.53M +$9.29M +1,300,000 New
NCM
7
Nantahala Capital Management
Connecticut
$8.32M -$2.14M -300,000 -21%
PAIM
8
Punch & Associates Investment Management
Minnesota
$5.83M
Geode Capital Management
9
Geode Capital Management
Massachusetts
$5.67M -$19.1K -2,673 -0.3%
Goldman Sachs
10
Goldman Sachs
New York
$5.47M +$142K +19,925 +3%
AIC
11
AWM Investment Company
New York
$4.49M -$4.84M -677,111 -52%
State Street
12
State Street
Massachusetts
$4.43M -$231K -32,378 -5%
TAM
13
Tocqueville Asset Management
New York
$3.06M +$250K +35,000 +9%
RA
14
Raffles Associates
New York
$2.95M +$286K +40,000 +11%
PCMI
15
Paradigm Capital Management Inc
New York
$2.93M
Renaissance Technologies
16
Renaissance Technologies
New York
$2.67M -$529K -74,100 -17%
DSCM
17
Divisadero Street Capital Management
Florida
$2.56M +$2.5M +349,792 New
CSC
18
Cove Street Capital
California
$2.56M +$188K +26,259 +8%
BA
19
Bard Associates
Illinois
$2.53M +$26.9K +3,762 +1%
Dimensional Fund Advisors
20
Dimensional Fund Advisors
Texas
$2.25M
Northern Trust
21
Northern Trust
Illinois
$2.07M +$28.3K +3,956 +1%
ACA
22
Apis Capital Advisors
New York
$1.79M +$71.4K +10,000 +4%
MAG
23
Millrace Asset Group
Pennsylvania
$1.7M +$193K +27,084 +13%
PM
24
Penbrook Management
New York
$1.57M -$127K -17,750 -8%
PAM
25
Panagora Asset Management
Massachusetts
$1.47M -$515K -72,120 -26%

VMD Hedge Fund Activity: Q3 2024 in Review

121 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Viemed Healthcare (VMD) for Q3 2024, worth a combined $186M — up 11% from $167M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new VMD positions and 15 closed out — a net gain of 6 holders — while 41 added to existing stakes and 26 trimmed.

The largest buyer was Divisadero Street Capital Management, opening a new position worth an estimated $2.5M. The largest seller was AWM Investment Company, cutting an estimated $4.84M.

  • 121 institutional investors held Viemed Healthcare (VMD) as of Q3 2024, up from 116 in Q2 2024.
  • Funds reported $186M of Viemed Healthcare stock for Q3 2024, up 11% quarter-over-quarter.
  • 21 funds opened new Viemed Healthcare positions in Q3 2024 and 15 closed out, a net change of +6 holders.
  • The largest Viemed Healthcare buyer in Q3 2024 was Divisadero Street Capital Management, an estimated $2.5M added.
  • The largest Viemed Healthcare seller in Q3 2024 was AWM Investment Company, an estimated $4.84M sold.

Based on aggregated 13F filings for Q3 2024.